| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maria Sabrina Spano, Liana Fattore, Francesca Cadeddu, Walter Fratta, Paola Fadd. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology. vol 225. issue 3. 2013-06-21. PMID:22903392. |
yet, schizophrenic patients often smoke cannabis as a form of self-medication to counter the aversive symptoms of schizophrenia. |
2013-06-21 |
2023-08-12 |
rat |
| Brian D Power, Milan Dragovic, Assen Jablensky, Nikos C Stefani. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia? The Australian and New Zealand journal of psychiatry. vol 47. issue 1. 2013-06-17. PMID:23042939. |
the present study was designed to test the hypothesis that consumption of amphetamine and/or cocaine in addition to cannabis would lead to an earlier age at onset of schizophrenia than that seen for cannabis consumption alone. |
2013-06-17 |
2023-08-12 |
Not clear |
| Michael Kiang, Bruce K Christensen, David L Streiner, Carolyn Roy, Iulia Patriciu, Robert B Zipursk. Association of abnormal semantic processing with delusion-like ideation in frequent cannabis users: an electrophysiological study. Psychopharmacology. vol 225. issue 1. 2013-06-10. PMID:22782461. |
frequent cannabis use is a risk marker for schizophrenia and delusions, but the neurocognitive mechanisms of this relationship remain unclear. |
2013-06-10 |
2023-08-12 |
Not clear |
| Douglas L Boggs, Deanna L Kelly, Fang Liu, Jared A Linthicum, Hailey Turner, Jennifer R Schroeder, Robert P McMahon, David A Gorelic. Cannabis withdrawal in chronic cannabis users with schizophrenia. Journal of psychiatric research. vol 47. issue 2. 2013-06-07. PMID:23146560. |
cannabis withdrawal in chronic cannabis users with schizophrenia. |
2013-06-07 |
2023-08-12 |
Not clear |
| Douglas L Boggs, Deanna L Kelly, Fang Liu, Jared A Linthicum, Hailey Turner, Jennifer R Schroeder, Robert P McMahon, David A Gorelic. Cannabis withdrawal in chronic cannabis users with schizophrenia. Journal of psychiatric research. vol 47. issue 2. 2013-06-07. PMID:23146560. |
chronic users of cannabis often report withdrawal symptoms after abstinence from use, but little is known about cannabis withdrawal in people with schizophrenia. |
2013-06-07 |
2023-08-12 |
Not clear |
| Victoria S Dalton, Mathieu Verdurand, Adam Walker, Deborah M Hodgson, Katerina Zavitsano. Synergistic Effect between Maternal Infection and Adolescent Cannabinoid Exposure on Serotonin 5HT1A Receptor Binding in the Hippocampus: Testing the "Two Hit" Hypothesis for the Development of Schizophrenia. ISRN psychiatry. vol 2012. 2013-06-06. PMID:23738203. |
infections during pregnancy and adolescent cannabis use have both been identified as environmental risk factors for schizophrenia. |
2013-06-06 |
2023-08-12 |
rat |
| Serena Deian. Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Drug testing and analysis. vol 5. issue 1. 2013-06-03. PMID:23109356. |
cannabidiol: a new light for schizophrenia? |
2013-06-03 |
2023-08-12 |
Not clear |
| Serena Deian. Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Drug testing and analysis. vol 5. issue 1. 2013-06-03. PMID:23109356. |
evidence suggests an association between cannabis and schizophrenia: schizophrenics show a higher use of marijuana as compared to the healthy population. |
2013-06-03 |
2023-08-12 |
Not clear |
| Anand Gururajan, Elizabeth E Manning, Maren Klug, Maarten van den Buus. Drugs of abuse and increased risk of psychosis development. The Australian and New Zealand journal of psychiatry. vol 46. issue 12. 2013-05-23. PMID:22833579. |
there is considerable evidence to suggest that the abuse of illicit drugs, particularly cannabis and methamphetamine, has aetiological roles in the pathogenesis of psychosis and schizophrenia. |
2013-05-23 |
2023-08-12 |
Not clear |
| Kirsty E Scholes-Balog, Mathew T Martin-Iverso. Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. Human psychopharmacology. vol 26. issue 6. 2013-05-17. PMID:21800361. |
cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. |
2013-05-17 |
2023-08-12 |
Not clear |
| Kirsty E Scholes-Balog, Mathew T Martin-Iverso. Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. Human psychopharmacology. vol 26. issue 6. 2013-05-17. PMID:21800361. |
schizophrenia patients and healthy cannabis users show different attention-dependant alterations in prepulse inhibition (ppi). |
2013-05-17 |
2023-08-12 |
Not clear |
| Kirsty E Scholes-Balog, Mathew T Martin-Iverso. Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. Human psychopharmacology. vol 26. issue 6. 2013-05-17. PMID:21800361. |
it is of interest then to examine ppi in patients with schizophrenia who use cannabis, given the hypothesized association between cannabis use and schizophrenia. |
2013-05-17 |
2023-08-12 |
Not clear |
| K A Gleason, S G Birnbaum, A Shukla, S Ghos. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Translational psychiatry. vol 2. 2013-05-16. PMID:23188199. |
clinical studies report associations between cannabis use during adolescence and later onset of schizophrenia. |
2013-05-16 |
2023-08-12 |
mouse |
| K A Gleason, S G Birnbaum, A Shukla, S Ghos. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Translational psychiatry. vol 2. 2013-05-16. PMID:23188199. |
these data suggest that significant cannabis use during adolescence may be a contributory causal factor in the development of certain features of schizophrenia and may offer mglur5 as a potential therapeutic target. |
2013-05-16 |
2023-08-12 |
mouse |
| Munish Aggarwal, Anindya Banerjee, Shubh Mohan Singh, S K Mattoo, D Bas. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Asian journal of psychiatry. vol 5. issue 3. 2013-05-03. PMID:22981049. |
the most common type of psychosis was schizophrenia like psychosis, being more common in the cannabis group. |
2013-05-03 |
2023-08-12 |
human |
| H Bugra, C Rapp, E Studerus, J Aston, S Borgwardt, A Riecher-Rössle. [Can cannabis use increase the risk for schizophrenic psychoses?]. Fortschritte der Neurologie-Psychiatrie. vol 80. issue 11. 2013-04-29. PMID:23139065. |
(ii) patients with schizophrenia abuse cannabis more often than age-matched healthy controls. |
2013-04-29 |
2023-08-12 |
Not clear |
| J C Arnold, A A Boucher, T Kar. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Current pharmaceutical design. vol 18. issue 32. 2013-03-25. PMID:22716133. |
the yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. |
2013-03-25 |
2023-08-12 |
Not clear |
| J C Arnold, A A Boucher, T Kar. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Current pharmaceutical design. vol 18. issue 32. 2013-03-25. PMID:22716133. |
there is substantial epidemiological evidence showing that cannabis increases the risk of psychosis, whereas other research suggests that schizophrenia patients self-medicate with the substance. |
2013-03-25 |
2023-08-12 |
Not clear |
| Anna Buadze, Stefan Kaiser, Rudolf Stohler, Wulf Roessler, Erich Seifritz, Michael Liebren. Patient's perceptions of the cannabis-psychosis link--a systematic review. Current pharmaceutical design. vol 18. issue 32. 2013-03-25. PMID:22716137. |
over the past years a growing research effort has investigated the relation between cannabis use and schizophrenia at a neurobiological, epidemiological and clinical level. |
2013-03-25 |
2023-08-12 |
human |
| Anna Buadze, Stefan Kaiser, Rudolf Stohler, Wulf Roessler, Erich Seifritz, Michael Liebren. Patient's perceptions of the cannabis-psychosis link--a systematic review. Current pharmaceutical design. vol 18. issue 32. 2013-03-25. PMID:22716137. |
the vast majority of patients with either schizophrenia or a recent psychosis disagreed with a causal link between cannabis use and their mental illness. |
2013-03-25 |
2023-08-12 |
human |